{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:15:14Z","timestamp":1767838514859,"version":"3.49.0"},"reference-count":45,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"abstract":"<jats:title>ABSTRACT.<\/jats:title>\n<jats:p>The rising prevalence of <jats:italic>Plasmodium vivax<\/jats:italic> (<jats:italic>P. vivax<\/jats:italic>) malaria challenges elimination efforts, particularly in the Greater Mekong Subregion, although adherence to the required 14-day primaquine (PQ) regimen remains a major obstacle. This study evaluated the effectiveness of a family-administered, directly observed treatment intervention in improving adherence to PQ among patients with confirmed <jats:italic>P. vivax <\/jats:italic>from October 2022 to March 2023. A cluster-randomized controlled trial was conducted in five intervention villages and five control villages in Kachin State, Myanmar. A total of 427 patients in the intervention group (supervised dosing) and 425 patients in the control group (unsupervised dosing), all diagnosed with <jats:italic>P. vivax<\/jats:italic>, underwent a 14-day PQ regimen, with the intervention group being supervised by trained family members. Pill counts on day 14 were assessed and compared between the two groups using Poisson generalized linear mixed models. Parasite reappearance identified by polymerase chain reaction was compared between the two groups using survival analysis. Cumulative malaria incidence at baseline, as well as at months 6 and 12, was compared between the two groups. Treatment adherence was significantly higher in the intervention group (98.8%) compared with the control group (77.6%). Parasite reappearance rates were similar between the groups (<jats:italic>P<\/jats:italic> = 0.20) on days 14, 28, and 42. However, the cumulative incidence of malaria over 1 year was significantly lower in the intervention group (<jats:italic>P<\/jats:italic> &lt;0.001) compared with the control group. In malaria-endemic areas with limited resources, a family-administered, directly observed treatment intervention offers an efficient approach to enhance PQ adherence and achieve the radical cure of <jats:italic>P. vivax<\/jats:italic> malaria.<\/jats:p>","DOI":"10.4269\/ajtmh.24-0814","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T20:33:42Z","timestamp":1746563622000},"page":"57-66","source":"Crossref","is-referenced-by-count":2,"title":["Enhancing Primaquine Adherence for Plasmodium vivax Malaria: A Cluster-Randomized Controlled Trial in Myanmar"],"prefix":"10.4269","volume":"113","author":[{"given":"Kyawt Mon","family":"Win","sequence":"first","affiliation":[{"name":"Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;"},{"name":"Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;"},{"name":"Department of Public Health, Ministry of Health, Naypyidaw, Myanmar;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pyae Linn","family":"Aung","sequence":"additional","affiliation":[{"name":"Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nay Yi Yi","family":"Linn","sequence":"additional","affiliation":[{"name":"Department of Public Health, Ministry of Health, Naypyidaw, Myanmar;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zau","family":"Ring","sequence":"additional","affiliation":[{"name":"State Public Health Department, Kachin, Myanmar;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myat Phone","family":"Kyaw","sequence":"additional","affiliation":[{"name":"Myanmar Health Network Organization, Yangon, Myanmar;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Nguitragool","sequence":"additional","affiliation":[{"name":"Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;"},{"name":"Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwang","family":"Cui","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and International Medicine, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jetsumon","family":"Sattabongkot","sequence":"additional","affiliation":[{"name":"Mahidol Vivax Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saranath","family":"Lawpoolsri","sequence":"additional","affiliation":[{"name":"Department of Tropical Hygiene, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2795","reference":[{"key":"b1","series-title":"World Malaria Report 2023","year":"2023"},{"key":"b2","series-title":"National Malaria Control Programme. National Plan for Malaria Elimination in Myanmar (2016\u20132030)","year":"2021"},{"key":"b3","series-title":"Guidelines for Malaria Diagnosis and Treatment in Myanmar (Annex 4)","year":"2015"},{"key":"b4","series-title":"Control and Elimination of Plasmodium vivax Malaria: A Technical Brief","year":"2015"},{"key":"b5","series-title":"Malar J","first-page":"280","article-title":"Primaquine radical cure of Plasmodium vivax: A critical review of the literature","volume":"11","author":"John","year":"2012"},{"key":"b6","series-title":"Malar J","first-page":"297","article-title":"Determinants of relapse periodicity in Plasmodium vivax malaria","volume":"10","author":"White","year":"2011"},{"key":"b7","series-title":"Cad Saude Publica","first-page":"1403","article-title":"Factors associated with recurrent Plasmodium vivax malaria in Porto Velho, Rondonia State, Brazil, 2009","volume":"30","author":"Simoes","year":"2014"},{"key":"b8","series-title":"J Health Popul Nutr","first-page":"4","article-title":"Adherence to antimalarial drug therapy among vivax malaria patients in northern Thailand","volume":"27","author":"Khantikul","year":"2009"},{"key":"b9","series-title":"Malar J","first-page":"355","article-title":"Adherence to Plasmodium vivax malaria treatment in the Brazilian Amazon Region","volume":"10","author":"Pereira","year":"2011"},{"key":"b10","series-title":"Malar J","first-page":"162","article-title":"Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: A mixed-methods study","volume":"22","author":"Rahmalia","year":"2023"},{"key":"b11","series-title":"Trop Med Int Health","first-page":"744","article-title":"Barriers to prompt and effective treatment of malaria in northern Sri Lanka","volume":"7","author":"Reilley","year":"2002"},{"key":"b12","series-title":"PLoS Med","first-page":"e1003494","article-title":"Towards the elimination of Plasmodium vivax malaria: Implementing the radical cure","volume":"18","author":"Thriemer","year":"2021"},{"key":"b13","series-title":"Oman Med J","first-page":"155","article-title":"Patient medication adherence: Measures in daily practice","volume":"26","author":"Jimmy","year":"2011"},{"key":"b14","series-title":"Med Pharm Rep","first-page":"117","article-title":"An overview of the common methods used to measure treatment adherence","volume":"92","author":"Anghel","year":"2019"},{"key":"b15","series-title":"Lancet Reg Health Southeast Asia","first-page":"100199","article-title":"Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India","volume":"13","author":"Rahi","year":"2023"},{"key":"b16","series-title":"Southeast Asian J Trop Med Public Health","first-page":"9","article-title":"Directly observed therapy with primaquine to reduce the recurrence rate of plasmodium vivax infection along the Thai-Myanmar border","volume":"42","author":"Maneeboonyang","year":"2011"},{"key":"b17","series-title":"Malar J","first-page":"308","article-title":"Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border","volume":"9","author":"Takeuchi","year":"2010"},{"key":"b18","series-title":"Malar J","first-page":"44","article-title":"The feasibility, patterns of use and acceptability of using mobile phone text-messaging to improve treatment adherence and post-treatment review of children with uncomplicated malaria in western Kenya","volume":"13","author":"Otieno","year":"2014"},{"key":"b19","series-title":"Malar J","first-page":"302","article-title":"Interventions for promoting patients\u2019 adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: A qualitative study among key stakeholders","volume":"22","author":"Win","year":"2023"},{"key":"b20","series-title":"Comput Biol Med","first-page":"113","article-title":"Sample size calculator for cluster randomized trials","volume":"34","author":"Campbell","year":"2004"},{"key":"b21","series-title":"Int Congress Trop Med Malaria Australia","article-title":"Adherence to Primaquine treatment in six states and regions in Myanmar","volume":"1184","author":"Lwin","year":"2016"},{"key":"b22","series-title":"National Strategic Plan for Malaria Elimination 2021\u20132025","year":"2020"},{"key":"b23","series-title":"Lancet","first-page":"903","article-title":"Family-member DOTS and community DOTS for tuberculosis control in Nepal: Cluster-randomised controlled trial","volume":"367","author":"Newell","year":"2006"},{"key":"b24","series-title":"R: A Language and Environment for Statistical Computing","year":"2023"},{"key":"b25","series-title":"Int J Tuberc Lung Dis","first-page":"1092","article-title":"Effectiveness of directly observed treatment of tuberculosis: A systematic review of controlled studies","volume":"18","author":"Tian","year":"2014"},{"key":"b26","series-title":"J Nepal Health Res Counc","first-page":"450","article-title":"Barriers to treatment compliance of directly observed treatment shortcourse among pulmonary tuberculosis patients","volume":"19","author":"Marahatta","year":"2021"},{"key":"b27","series-title":"Using Information, Education, and Communication (IEC) Programs to Improve Drug Adherence Among Vivax Malaria Patients in Northern Thailand","author":"Khantikul","year":"2008"},{"key":"b28","series-title":"Trop Dis Travel Med Vaccines","first-page":"27","article-title":"Plasmodium vivax: The potential obstacles it presents to malaria elimination and eradication","volume":"8","author":"Habtamu","year":"2022"},{"key":"b29","series-title":"Lancet","first-page":"929","article-title":"Short-course primaquine for the radical cure of Plasmodium vivax malaria: A multicentre, randomised, placebo-controlled non-inferiority trial","volume":"394","author":"Taylor","year":"2019"},{"key":"b30","series-title":"Trans R Soc Trop Med Hyg","first-page":"751","article-title":"Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal","volume":"102","author":"Souares","year":"2008"},{"key":"b31","series-title":"N Engl J Med","first-page":"800","article-title":"The treatment of malaria","volume":"335","author":"White","year":"1996"},{"key":"b32","series-title":"Cochrane Database Syst Rev","first-page":"CD004389","article-title":"Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine","volume":"2013","author":"Galappaththy","year":"2013"},{"key":"b33","series-title":"Sci Rep","first-page":"5963","article-title":"Factors hindering coverage of targeted mass treatment with primaquine in a malarious township of northern Myanmar in 2019\u20132020","volume":"13","author":"Aung","year":"2023"},{"key":"b34","series-title":"Parasites Hosts Dis","first-page":"154","article-title":"Prevalence and molecular analysis of glucose-6-phosphate dehydrogenase deficiency in Chin State, Myanmar","volume":"61","author":"Aung","year":"2023"},{"key":"b35","series-title":"Trop Med Health","first-page":"47","article-title":"G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination","volume":"49","author":"Han","year":"2021"},{"key":"b36","series-title":"BMC Infect Dis","first-page":"131","article-title":"Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency among malaria patients in Upper Myanmar","volume":"18","author":"Lee","year":"2018"},{"key":"b37","series-title":"Malar J","first-page":"170","article-title":"Plasmodium vivax and Plasmodium falciparum infection dynamics: Re-infections, recrudescences and relapses","volume":"17","author":"White","year":"2018"},{"key":"b38","series-title":"Mol Ther Methods Clin Dev","first-page":"427","article-title":"Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine","volume":"26","author":"Flannery","year":"2022"},{"key":"b39","series-title":"J Travel Med","first-page":"taz023","article-title":"Tafenoquine and G6PD: A primer for clinicians","volume":"26","author":"Chu","year":"2019"},{"key":"b40","series-title":"Infect Dis Poverty","first-page":"95","article-title":"Lessons on malaria control in the ethnic minority regions in Northern Myanmar along the China border, 2007\u20132014","volume":"5","author":"Wang","year":"2016"},{"key":"b41","series-title":"Harm Reduct J","first-page":"45","article-title":"The effect of different types of migration on symptoms of anxiety or depression and experience of violence among people who use or inject drugs in Kachin State, Myanmar","volume":"20","author":"Kyaw","year":"2023"},{"key":"b42","series-title":"Malar J","first-page":"124","article-title":"Epidemiological profiles of recurrent malaria episodes in an endemic area along the Thailand-Myanmar border: A prospective cohort study","volume":"18","author":"Lawpoolsri","year":"2019"},{"key":"b43","series-title":"Infection","first-page":"681","article-title":"Therapeutic efficacy of chloroquine for uncomplicated Plasmodium vivax malaria in southeastern and western border areas of Myanmar","volume":"50","author":"Soe","year":"2022"},{"key":"b44","series-title":"Travel Med Infect Dis","first-page":"101499","article-title":"Efficacy of directly-observed chloroquine-primaquine treatment for uncomplicated acute Plasmodium vivax malaria in northeast Myanmar: A prospective open-label efficacy trial","volume":"36","author":"Xu","year":"2020"},{"key":"b45","series-title":"Int J Equity Health","first-page":"39","article-title":"Community stressors and coping mechanisms in accessing the health system during a double crisis: A qualitative case study from Yangon Region, Myanmar","volume":"22","author":"Kyaw","year":"2023"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/113\/1\/article-p57.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/113\/1\/article-p57.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/113\/1\/article-p57.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:54:19Z","timestamp":1751464459000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/113\/1\/article-p57.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":45,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.24-0814","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]}}}